Sviluppo di vettori virali per la terapia genica della β−Talassemia
Year: 2012
Type: dissertation
Abstract: Beta−thalassemia major is a severe congenital anemi for\t which there is presently no curative therapy other than allogeneic hematopoietic stem cell transplantation. This therapeutic option, however, applies only to the minority of thalassemia patients\twho have an HLA−matched\tbone marrow donor. Gene therapy by the delivery of a regulated globin gene to\tautologous hematopoietic stem cells is an attractive alternative approach as it is in principle\tapplicable to all thalassemic subjects.\tCurrent vectors, althougheffective in correcting\tthalassemia in\tmurine models\tstill suffer some drawbacks in terms of\tsafety\tand also in\tterms of low titer and expression. The\taim of this study was to assemble globin vectors improved in both these aspects. Modifications of the globin cassette in\tthe intron2\tand in the LCR of the beta-‐globin gene\tcan increase the expression\tof the globin gene without reducing the vector titer. We also examine the variegation in the expression among the different pools of transduce cells\t and we suppose that the presence of sequences with chromatin opening activity among the segments of b-‐globin IVS2
Author: Annalisa Cabriolu
Institution: University of Cagliari
Language: Italian
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W609725101
